imipramine has been researched along with Lewy Body Disease in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Lewy Body Disease: A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballard, C | 1 |
| Johnson, M | 1 |
| Piggott, M | 1 |
| Perry, R | 1 |
| O'Brien, J | 1 |
| Rowan, E | 1 |
| Perry, E | 1 |
| Lantos, P | 1 |
| Cairns, N | 1 |
| Holmes, C | 1 |
1 other study available for imipramine and Lewy Body Disease
| Article | Year |
|---|---|
A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Autoradiography; Binding Sites; Carrier Proteins; Depressive Disorder; Fema | 2002 |